Laquinimod
Results: 5
# | Item |
---|---|
1 | Issue 14 l[removed]l Disease courses in MS MSIF14 pp01 cover.indd 1Add to Reading ListSource URL: www.msif.orgLanguage: English - Date: 2014-10-14 05:17:55 |
2 | Active Biotech and Ipsen to presentAdd to Reading ListSource URL: hugin.infoLanguage: English - Date: 2014-08-13 16:29:09 |
3 | Modifying disability in progressive multiple sclerosisAdd to Reading ListSource URL: download.thelancet.comLanguage: English |
4 | Teva och Active Biotech fortsätter utvecklingen av NERVENTRA® (laquinimod) för multipel skleros efter bekräftat utlåtande från CHMP JERUSALEM, Israel & LUND, Sverige, den 23 maj, 2014 – Teva Pharmaceutical IndustAdd to Reading ListSource URL: hugin.infoLanguage: Swedish - Date: 2014-05-22 13:04:02 |
5 | Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsyAdd to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |